Clinical Trial Update: Effects of Empagliflozin on Diuresis and Renal Function in Patients With Acute Decompensated Heart Failure [Phase 2]

View source ↗

Summary

Phase 2 trial updating on the effects of empagliflozin on diuresis and renal function in patients with acute decompensated heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Heart Failure

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Christian Schulze | Conditions: Acute Decompensated Heart Failure | Phase 2 | Status: COMPLETED